Breast cancer screening: Successes and challenges

CA Cancer Journal for Clinicians

Volumn 62, Issue 1, 2012, Pages 5-9

  Evans, W Phil ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CANCER; BREAST EXAMINATION; BREAST SELF EXAMINATION; CANCER CONTROL; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC VALUE; DIGITAL MAMMOGRAPHY; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MEDICAL TECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SENSITIVITY ANALYSIS; SURVIVAL RATE; TREND STUDY;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MORBIDITY; SURVIVAL RATE; UNITED STATES;

EID: 84855789887     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.20137     Document Type: Review

References (33)

1. Altekruse SF, Kosary CL, Krapcho M, et al, eds. Surveillance, Epidemiology, and End Results Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010. Available at:, based on November 2009 SEER data submission, posted to the SEER Web site, 2010.
2. Jemal A, Ward E, Thun M,. Declining death rates reflect progress against cancer. PLoS One. 2010; 5: e9584.
3. Berry DA, Cronin KA, Plevritis SK, et al. Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784-1792. (Pubitemid 41549890)
4. Duffy SW, Tabar L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 2002; 95: 458-469. (Pubitemid 34810170)
5. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006; 15: 45-51.
6. Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA,. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001; 91: 1724-1731. (Pubitemid 32377958)
7. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2011; 117: 714-722.
8. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet. 2003; 361: 1411-1417. (Pubitemid 36515040)
9. Shapiro S, Venet W, Strax P, Venet L, Roeser R,. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr. 1985; 67: 65-74. (Pubitemid 15031263)
10. Seidman H, Gelb SK, Silverberg E, LaVerda N, Lubera JA,. Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin. 1987; 37: 258-290. (Pubitemid 17153469)
11. Miller AB, Baines CJ, To T, Wall C,. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [erratum, Can Med Assoc J. 1993; 148: 718 ]. CMAJ. 1992; 147: 1459- 1476.
12. Bailar JC 3rd, MacMahon B,. Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion. CMAJ. 1997; 156: 193-199. (Pubitemid 27065011)
13. Coldman A, Phillips N, Warren L, Kan L,. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer. 2007; 120: 1076-1080. (Pubitemid 46214308)
14. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW,. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003; 361: 1405-1410. (Pubitemid 36515039)
15. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L,; U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151: 727-737.
16. Rosenberg RD, Yankaskas BC, Abraham LA, et al. Performance benchmarks for screening mammography. Radiology. 2006; 241: 55-66. (Pubitemid 44433335)
17. Hendrick RE, Helvie MA,. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 2011; 196: W112-W116.
18. Fletcher SW, Elmore JG,. Clinical practice. Mammographic screening for breast cancer. N Engl J Med. 2003; 348: 1672-1680. (Pubitemid 36459474)
19. NIH Consensus Statement. Breast cancer screening for women ages 40-49. NIH Consens Statement. 1997; 15: 1-35.
20. Jorgensen KJ, Gotzsche PC,. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009; 339: b2587.
21. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP,. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006; 332: 689-692.
22. Duffy SW, Agbaje O, Tabar L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res. 2005; 7: 258-265. (Pubitemid 41830164)
23. Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW,. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J. 2006; 12: 338-342. (Pubitemid 43989978)
24. Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E,. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer. 2009; 45: 3166-3171.
25. Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000; 38: 625-651. (Pubitemid 30640056)
26. Berg WA, Blume JD, Cormack JB, et al. ACRIN 6666 Investigators. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008; 299: 2151-2163. (Pubitemid 351679706)
27. Berg WA,. Tailored supplemental screening for breast cancer: what now and what next? AJR Am J Roentgenol. 2009; 192: 390-399.
28. McDonald S, Saslow D, Alciati MH,. Performance and reporting of clinical breast examination: a review of the literature. CA Cancer J Clin. 2004; 54: 345-361. (Pubitemid 40073991)
29. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW,. Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2011; 61: 8-30.
30. Baxter N,; Canadian Task Force on Preventive Health Care. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? CMAJ. 2001; 164: 1837-1846. (Pubitemid 32702068)
31. Breen N, Cronin KA, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer. 2007; 109: 2405-2409. (Pubitemid 46906458)
32. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006; 144: 541-553. (Pubitemid 46768143)
33. Lund MJ, Brawley OW, Ward KC, Young JL, Gabram SS, Eley JW,. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2008; 109: 545-557. (Pubitemid 351692062)